JHL Capital Group’s IVERIC bio, Inc. Common Stock ISEE Stock Holding History

JHL Capital Group’s Portfolio ISEE Stock Details ISEE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-3,000,000	Closed	-$138M	–	21
2016 Q3	$138M	Sell	3,000,000 -265,000	-8%	-$14.9M	9.08%	2
2016 Q2	$167M	Hold	3,265,000	–	–	20.59%	1
2016 Q1	$138M	Hold	3,265,000	–	–	13.19%	2
2015 Q4	$256M	Hold	3,265,000	–	–	22.47%	1
2015 Q3	$132M	Hold	3,265,000	–	–	14.63%	1
2015 Q2	$170M	Hold	3,265,000	–	–	12.71%	2
2015 Q1	$152M	Hold	3,265,000	–	–	13.98%	2
2014 Q4	$147M	Buy	3,265,000 +195,000	+6%	+$8.19M	9.66%	4
2014 Q3	$120M	Buy	3,070,000 +340,000	+12%	+$13.3M	6.49%	5
2014 Q2	$116M	Buy	2,730,000 +1,520,000	+126%	+$55.8M	5.57%	4
2014 Q1	$43.2M	Buy	1,210,000 +965,000	+394%	+$32.6M	3.05%	7
2013 Q4	$7.93M	Buy	245,000 +55,000	+29%	+$1.63M	0.71%	22
2013 Q3	$5.64M	Buy	+190,000	New	+$5.39M	0.96%	15

Other funds holding ISEE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

SCM

Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

TCP

Tourbillon Capital Partners New York $6.26M AUM 42.29% 1-Year Est. Return

BIM

Bogle Investment Management Newton Lower Falls, Massachusetts $63M AUM 51.97% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Fiera Capital (Canada) Montreal, Quebec, Canada $29.2B AUM 20.16% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

JHL Capital Group's ISEE Position: Q4 2016 in Review

JHL Capital Group sold out of IVERIC bio, Inc. Common Stock (ISEE) in Q4 2016, closing a stake of 3,000,000 shares — an estimated $138M sold.

JHL Capital Group first reported a position in ISEE in Q3 2013 and held it in 13 quarters. The position peaked at $256M in Q4 2015. 137 funds tracked by Wall St. Rank hold ISEE as of Q4 2016.

JHL Capital Group reported no remaining IVERIC bio, Inc. Common Stock position as of Q4 2016 after selling out during the quarter.
JHL Capital Group sold 3,000,000 IVERIC bio, Inc. Common Stock shares in Q4 2016, an estimated $138M.
JHL Capital Group first reported a position in IVERIC bio, Inc. Common Stock in Q3 2013 and held it in 13 quarters.
JHL Capital Group's IVERIC bio, Inc. Common Stock position peaked at $256M in Q4 2015.
137 funds tracked by Wall St. Rank held IVERIC bio, Inc. Common Stock as of Q4 2016.

Based on JHL Capital Group's 13F filing for Q4 2016, filed 14 Feb 2017.